Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reduced prevalence of arterial thrombosis in von Willebrand disease.
Sanders YV, Eikenboom J, de Wee EM, van der Bom JG, Cnossen MH, Degenaar-Dujardin ME, Fijnvandraat K, Kamphuisen PW, Laros-van Gorkom BA, Meijer K, Mauser-Bunschoten EP, Leebeek FW; WiN Study Group. Sanders YV, et al. Among authors: fijnvandraat k. J Thromb Haemost. 2013 May;11(5):845-54. doi: 10.1111/jth.12194. J Thromb Haemost. 2013. PMID: 23506463 Free article.
Obesity: a new disaster for haemophilic patients? A nationwide survey.
Hofstede FG, Fijnvandraat K, Plug I, Kamphuisen PW, Rosendaal FR, Peters M. Hofstede FG, et al. Among authors: fijnvandraat k. Haemophilia. 2008 Sep;14(5):1035-8. doi: 10.1111/j.1365-2516.2008.01806.x. Epub 2008 Jul 15. Haemophilia. 2008. PMID: 18637967
Inhibitors of factor VIII in hemophilia.
Eckhardt CL, Kamphuisen PW, Fijnvandraat K. Eckhardt CL, et al. Among authors: fijnvandraat k. N Engl J Med. 2009 Jul 16;361(3):309; author reply 310. N Engl J Med. 2009. PMID: 19610163 No abstract available.
Health-related quality of life among adult patients with moderate and severe von Willebrand disease.
de Wee EM, Mauser-Bunschoten EP, Van Der Bom JG, Degenaar-Dujardin ME, Eikenboom HC, Fijnvandraat K, de Goede-Bolder A, Laros-van Gorkom BA, Meijer K, Raat H, Leebeek FW; Win Study Group. de Wee EM, et al. Among authors: fijnvandraat k. J Thromb Haemost. 2010 Jul;8(7):1492-9. doi: 10.1111/j.1538-7836.2010.03864.x. Epub 2010 Mar 23. J Thromb Haemost. 2010. PMID: 20345712 Free article.
Impact of von Willebrand disease on health-related quality of life in a pediatric population.
de Wee EM, Fijnvandraat K, de Goede-Bolder A, Mauser-Bunschoten EP, Eikenboom JC, Brons PP, Smiers FJ, Tamminga R, Oostenbrink R, Raat H, van der Bom JG, Leebeek FW; WiN Study Group. de Wee EM, et al. Among authors: fijnvandraat k. J Thromb Haemost. 2011 Mar;9(3):502-9. doi: 10.1111/j.1538-7836.2010.04175.x. J Thromb Haemost. 2011. PMID: 21166992 Free article.
Surgery and inhibitor development in hemophilia A: a systematic review.
Eckhardt CL, van der Bom JG, van der Naald M, Peters M, Kamphuisen PW, Fijnvandraat K. Eckhardt CL, et al. Among authors: fijnvandraat k. J Thromb Haemost. 2011 Oct;9(10):1948-58. doi: 10.1111/j.1538-7836.2011.04467.x. J Thromb Haemost. 2011. PMID: 21838755 Free article. Review.
Effect of fibrinolysis on bleeding phenotype in moderate and severe von Willebrand disease.
De Wee EM, Klaij K, Eikenboom HC, Van Der Bom JG, Fijnvandraat K, Laros-Van Gorkom BA, Mauser-Bunschoten EP, Meijer K, Goverde G, Van Der Linden PW, Rijken DC, Leebeek FW; WiN Study Group. De Wee EM, et al. Among authors: fijnvandraat k. Haemophilia. 2012 May;18(3):444-51. doi: 10.1111/j.1365-2516.2011.02645.x. Epub 2011 Sep 12. Haemophilia. 2012. PMID: 21910790
Gynaecological and obstetric bleeding in moderate and severe von Willebrand disease.
De Wee EM, Knol HM, Mauser-Bunschoten EP, van der Bom JG, Eikenboom JC, Fijnvandraat K, De Goede-Bolder A, Laros-van Gorkom B, Ypma PF, Zweegman S, Meijer K, Leebeek FW; WiN study group. De Wee EM, et al. Among authors: fijnvandraat k. Thromb Haemost. 2011 Nov;106(5):885-92. doi: 10.1160/TH11-03-0180. Epub 2011 Sep 22. Thromb Haemost. 2011. PMID: 21947221
219 results